Abstract
Polyether glycosidic ionophores and macrocyclic glycosides are of great interest, especially for the medicinal and pharmaceutical industries. These biologically active natural surfactants are good prospects for the future chemical preparation of compounds useful as antibiotics, anticancer agents, or in industry. More than 300 interesting and unusual natural surfactants are described in this review article, including their chemical structures and biological activities.
Similar content being viewed by others
Abbreviations
- EC50 :
-
the median effect concentration, being a statistically-derived concentration of a substance that can be expected to cause (i) an adverse reaction in 50% of organisms or (ii) a 50% reduction in growth or in the growth rate of organisms
- ED50 (effective dose50):
-
the amount of material required to produce a specified effect in 50% of an animal population
- GI:
-
growth inhibition
- GI50 :
-
the concentration needed to reduce the growth of treated cells to half that of untreated (i.e., control) cells
- HSV-1:
-
herpes simplex virus type 1
- IC:
-
inhibitory concentration
- IC50 :
-
concentration at which growth or activity is inhibited by 50% (applies to ligand and growth inhibition)
- %ILS:
-
percent increase in life span
- LC50 for drugs with a cytotoxic effect:
-
the concentration of drug at which 50% of cells die (a 50% reduction in the measured protein at the end of the drug treatment as compared with that at the beginning)
- LD50 (lethal dose50):
-
the dose of a chemical that kills 50% of a sample population
- log IC (log EC):
-
IC (or EC) in a log 10 scale (a log 10 scale is frequently used when x values are a serial dilution, as a better estimate of the SE is obtained)
- log GI50 :
-
log concentrations that reduced cell growth to 50% of the level at the start of the experiment
- log10 RC50 :
-
root elongation half inhibition concentration (mol/L) in logarithmic form
- LD:
-
lethal dose
- LD50 :
-
the dose at which 50% of test subjects die
- LPS:
-
lipopolysaccharide
- MIC:
-
minimal inhibitory concentration
- RC50 :
-
concentration at which there is a 50% reduction in the number of offspring as compared with controls
- TRAP:
-
tartrate-resistant acid phosphatase
- VZV:
-
varicella-zoster virus
References
Dembitsky, V.M. (2005) Astonishing Diversity of Natural Surfactants 1. Glycosides of Fatty Acids and Alcohols, Lipids 39, 933–953.
Dembitsky, V.M. (2004) Chemistry and Biodiversity of Biologically Active Natural Glycosides, Chem. Biodivers. 1, 673–781.
Kren, V., and Martinkova, L. (2001) Glycosides in Medicine: The Role of Glycosidic Residue in Biological Activity, Curr. Med. Chem. 8, 1303–1328.
Kingston, W. (2004) Streptomycin, Schatz v. Waksman, and the Balance of Credit for Discovery, J. Hist. Med. Allied Sci. 59, 441–462.
Ng, A.W., Wasan, K.M., and Lopez-Berestein, G. (2003) Development of Liposomal Polyene Antibiotics: An Historical Perspective, J. Pharm. Pharm. Sci. 6, 67–83.
Casnati, A., Sansone, F., and Ungaro, R. (2003) Peptido- and Glycocalixarenes: Playing with Hydrogen Bonds Around Hydrophobic Cavities, Acc. Chem. Res. 36, 246–254.
Sener, B. (ed.) (2002) Biodiversity: Biomolecular Aspects of Biodiversity and Innovative Utilization, Kluwer Academic/Plenum, New York.
Ernst, B., Hart, G.W., and Sinaÿ, P. (eds.) (2000) Carbohydrates in Chemistry and Biology, Wiley-VCH, Weinheim.
Satoshi, O. (ed.) (2002) Macrolide Antibiotics: Chemistry, Biology, and Practice, Amsterdam, Academic Press.
Rosen, M.J. (2004) Surfactants and Interfacial Phenomena, 3rd edn., John Wiley & Sons, New York.
Robinson, J.A. (1991) Chemical and Biochemical Aspects of Polyether-Ionophore Antibiotic Biosynthesis, Prog. Chem. Org. Nat. Prod. 58, 1–82.
Kirst, H.A. (1992) Macrolides, in Encyclopedia of Chemical Technology, 4th edn. (Howe-Grant, M., ed.), Vol. 3, pp. 169–213, John Wiley & Sons, New York.
Crandell, L.W., and Hamill, R.L. (1992) Antibiotics, Polyenes, in Encyclopedia of Chemical Technology, 4th edn. (Howe-Grant, M., ed.), Vol. 3, pp. 307–311, John Wiley & Sons, New York.
Szabo, G. (1981) Structural Aspects of Ionophore Function, Fed. Proc. 40, 2196–2201.
Krasne, S., and Eisenman, G. (1976) Influence of Molecular Variations of Ionophore and Lipid on the Selective Ion Permeability of Membranes: I. Tetranactin and the Methylation of Nonactin-type Carriers, J. Membr. Biol. 30, 1–44.
Szabo, G., Eisenman, G., Laprade, R., Ciani, S.M., and Krasne, S. (1973) Experimentally Observed Effects of Carriers on the Electrical Properties of Bilayer Membranes—Equilibrium Domain. With a Contribution on the Molecular Basis of Ion Selectivity, Membranes 2, 179–328.
Pressman, B.C., Harris, E.J., Jagger, W.S., and Johnson, J.M. (1967) Antibiotic-Mediated Transport of Alkali Ions Across Lipid Barriers, Proc. Natl. Acad. Sci. USA 58, 1949–1956.
Matsuoka, M., and Sasaki, T. (2004) Inactivation of Macrolides by Producers and Pathogens, Curr. Drug Targets Infect. Disord. 4, 217–240.
Goldman, R.C., and Scaglione, F. (2004) The Macrolide-Bacterium Interaction and Its Biological Basis, Curr. Drug Targets Infect. Disord. 4, 241–260.
Wheeler, J.J., Veiro, J.A., and Cullis, P.R. (1994) Ionophore-Mediated Loading of Ca2+ into Large Unilamellar Vesicles in Response to Transmembrane pH Gradients, Mol. Membr. Biol. 11, 151–157.
Somani, P., Kabell, G.G., Saini, R.K., and Hester, R.K. (1980) The Effect of Monensin, a Na+-Selective Carboxylic Ionophore, on Coronary Circulation, Adv Myocardiol. 2, 435–447.
Maravic, G. (2004) Macrolide Resistance Based on the Erm-Mediated rRNA Methylation, Curr. Drug Targets Infect. Disord. 4, 193–202.
Budanov, S.V., and Vasil'ev, A.N. (2004) Clarithromycin: Specific Features of Antimicrobial Spectrum and Clinical Use, Antibiot. Khimioter. (Russian) 49, 19–25.
Gotfried, M.H. (2004) Appropriate Outpatient Macrolide Use in Community-Acquired Pneumonia, J. Am. Acad. Nurse Pract. 16, 146–150.
Gotfried, M.H. (2003) Clarithromycin (Biaxin) Extended-Release Tablet: A Therapeutic Review, Expert Rev. Anti Infect. Ther. 1, 9–20.
Cazzola, M., Matera, M.G., and Blasi, F. (2004) Macrolide and Occult Infection in Asthma, Curr. Opin. Pulm. Med. 10, 7–14.
Neher, J.O., and Morton, J.R. (2004) What Is the Best Macrolide for Atypical Pneumonia? J. Fam. Pract. 53, 229–230.
Hammerschla g, M.R. (2003) Pneumonia Due to Chlamydia pneumoniae in Children: Epidemiology, Diagnosis, and Treatment, Pediatr. Pulmonol. 36, 384–390.
Satoshi, O. (ed.) (2002) Macrolide Antibiotics: Chemistry, Biology, and Practice, Academic Press, Amsterdam.
Schönfeld, W., and Kirst, H.A. (eds.) (2002) Macrolide Antibiotics, Birkhauser Verlag.
Burja, A.M., Banaigs, B., Abou-Mansour, E., Burgess, J.G., and Wright, P.C. (2001) Marine Cyanobacteria—A Prolific Source of Natural Products, Tetrahedron 57, 9347–9377.
Shimizu, Y. (2000) Microalgae as a Drug Source, in Drugs from the Sea (Fusetani, N., ed.), pp. 30–45, Karger, Basel.
Kobayashi, J., and Ishibashi, M. (1999) Marine Natural Products and Marine Chemical Ecology, in Comprehenstive Natural Products Chemistry (Mori, K., ed.), Vol. 8, pp. 415–649, Elsevier, Amsterdam.
Shimizu, Y. (1996) Microalgal Metabolites: A New Perspective, Annu. Rev. Microbiol. 50, 431–465.
Woodward, R.B. (1957) Struktur und Biogenese der Macrolide: Eine neue Klasse von Naturstoffen, Angew. Chem. 69, 50–62.
Moore, B.S., and Hopke, J.N. (2001) Discovery of a New Bacterial Polyketide Biosynthetic Pathway, Chembiochem. 2, 35–38.
McGuffey, R.K., Richardson, L.F., and Wilkinson, J.I.D. (2001) Ionophores for Dairy Cattle: Current Status and Future Outlook, J. Dairy Sci. 84, Suppl., E194-E203.
O'Hagan, D. (1991) The Polyketide Metabolites, Ellis Horwood, Chichester, United Kingdom.
Dutton, C.J., Banks, B.J., and Cooper, C.B. (1995) Polyether Ionophores, Nat. Prod. Rep. 12, 165–181.
Murata, M., and Yasumoto, T. (2000) The Structure Elucidation and Biological Activities of High Molecular Weight Algal Toxins: Maitotoxin, Prymnesins and Zooxanthellatoxins, Nat. Prod. Rep. 17, 293–314.
Rein, K.S., and Borrone, J. (1999) Polyketides from Dinoflagellates: Origins, Pharmacology and Biosynthesis, Comp. Biochem. Physiol. 124B, 117–131.
Faul, M.M., and Huff, B.E. (2000) Strategy and Methodology Development for the Total Synthesis of Polyether Ionophore Antibiotics, Chem. Rev. 100, 2407–2473.
Traxler, P., Gruner, J., and Auden, J.A.L. (1977) Papulacandins, A New Family of Antibiotics with Antifungal Activity, I. Fermentation, Isolation, Chemical and Biological Characterization of Papulacandins A, B, C, D and E, J. Antibiot. 30, 289–296.
Traxler, P., Fritz, H., and Richter, W.J. (1977) On the Structure of Papulacandin B, a New Antibiotic with Antifungal Activity, Helv. Chim. Acta 60, 578–584.
Traxler, P., Fritz, H., Fuhrer, H., and Richter, W.J. (1980) Papulacandins, a New Family of Antibiotics with Antifungal Activity. Structures of Papulacandins A, B, C and D, J. Antibiot. 33, 967–978.
Onishi, J., Meinz, M., Thompson, J., Curotto, J., Dreikorn, S., Rosenbach, M., Douglas, C., Abruzzo, G., Flattery, A., Kong, L., et al. (2000) Discovery of Novel Antifungal (1,3)-β-d-Glucan Synthase Inhibitors, Antimicrob. Agents Chemother. 44, 368–377.
Debono, M., and Gordee, R.S. (1994) Antibiotics That Inhibit Fungal Cell Wall Development, Annu. Rev. Microbiol. 48, 471–497.
Rommele, G., Traxler, P., and Wehrli, W. (1983) Papulacandins: The Relationship Between Chemical Structure and Effect on Glucan Synthesis in Yeast, J. Antibiot. 36, 1539–1542.
Kaneto, R., Chiba, H., Agematu, H., Shibamoto, N., Yoshioka, T., Nishada, H., and Okamoto, M. (1993) Mer-WF3010, a New Member of the Papulacandin Family. I. Fermentation, Isolation and Characterization, J. Antibiot. 46, 247–250.
Chiba, H., Kaneto, R., Agematu, H., Shibamoto, N., Yoshioka, T., Nishida, H., and Okamoto, R. (1993) Mer-WF3010, a New Member of the Papulacandin Family. II. Structure Determination, J. Antibiot. 46, 356–358.
Van Middlesworth, F., Omstead, M.N., Schmatz, D., Bartizal, K., Fromtling, R., Bills, G., Nollstadt, K., Honeycutt, S., Zweerink, M., Garrity, G., and Wilson, K. (1991) L-687,781, A New Member of the Papulacandin Family of β-1,3-d-Glucan Synthesis Inhibitors. 2. Fermentation, Isolation, and Biological Activity, J. Antibiot. 44, 45–51.
Chen, R.H., Tennant, S., Frost, D., O'Beirne, M.J., Karwowski, J.P., Humphrey, P.E., Malmberg, L.H., Choi, W., Brandt, K.D., West, P., et al. (1996) Discovery of Sarcandin, a Novel Papulacandin, from a Fusarium Species, J. Antibiot. 49, 596–598.
Kobayashi, J., Kubota, T., Takahashi, M., Ishibashi, M., Tsuda, M., and Naoki, H. (1999) Colopsinol A, a Novel Polyhydroxyl Metabolite from Marine Dinoflagellate Amphidinium sp., J. Org. Chem. 64, 1478–1482.
Kubota, T., Tsuda, M., Takahashi, M., Ishibashi, M., Naoki, H., and Kobayashi, J. (1999) Colopsinols B and C, New Long Chain Polyhydroxy Compounds from Cultured Marine Dinoflagellate Amphidinium sp., J. Chem. Soc., Perkin Trans. 1, 3483–3487.
Kubota, T., Tsuda, M., Takahashi, M., Ishibashi, M., Oka, S., and Kobayashi, J. (2000) Colopsinols D and E, New Polyhydroxyl Linear Carbon Chain Compounds from Marine Dinoflagellate Amphidinium sp., Chem. Pharm. Bull. 48, 1447–1451.
Mayer, A.M.S., and Gustafson, K.R. (2003) Marine Pharmacology in 2000: Antitumor and Cytotoxic Compounds, Int. J. Cancer 105, 291–299.
Westley, J.W. (1977) Polyether Antibiotics: Versatile Carboxylic Acid Ionophores Produced by Streptomyces, Adv. Appl. Microbiol. 22, 177–223.
Westley, J.W. (ed.) (1982) Polyether Antibiotics: Naturally Occurring Acid Ionophores, Biology, Marcel Dekker, New York.
Hopwood, D.A. (1997) Genetic Contributions to Understanding Polyketide Synthases, Chem. Rev. 97, 2465–2497.
Katz, L., and McDaniel, R. (1999) Novel Macrolides Through Genetic Engineering, Med. Res. Rev. 19, 543–558.
Tsou, H.R., Rajan, S., Fiala, R., Mowery, P.C., Bullock, M.W., Borders, D.B., James, J.C., Martin, J.H., and Morton, G.O. (1984) Biosynthesis of the Antibiotic Maduramicin. Origin of the Carbon and Oxygen Atoms as well as the 13C NMR Assignments, J. Antibiot. 37, 1651–1663.
Tsou, H.R., Rajan, S., Chang, T.T., Fiala, R.R., Stockton, G.W., and Bullock, M.W. (1987) The Utilization of Molecular Oxygen During the Biosynthesis of Maduramicin, J. Antibiot. 40, 94–99.
Mizoue, K., Seto, H., Mizutani, T., Yamagishi, M., Kawashima, A., Omura, S., Ozeki, M., and Otake, N. (1980) Studies on the Ionophorous Antibiotics. XXV. The Assignments of the 13C-NMR Spectra of Dianemycin and Lenoremycin, J. Antibiot. 33, 144–156.
Cane, D.E., and Hubbard, B.R. (1987) Polyether Biosynthesis. 3. Origin of the Carbon Skeleton and Oxygen Atoms of Lenoremycin, J. Am. Chem. Soc. 109, 6533–6535.
Imada, A., Nozaki, Y., Hasegawa, T., Mizuta, E., Igarasi, S., and Yoneda, M. (1978) Carriomycin, a New Polyether Antibiotic Produced by Streptomyces hygroscopicus, J. Antibiot. 31, 7–14.
Mitani, M., and Otake, N. (1978) Studies on the Ionophorous Antibiotics. XV. The Monovalent Cation Selective Ionophorous Activities of Carriomycin, Lonomycin and Etheromycin, J. Antibiot. 31, 750–755.
Tsuji, N., Nagashima, K., Kobayashi, M., Wakisaka, Y., and Kawamura, Y. (1976) Two New Antibiotics, A-218 and K-41. Isolation and Characterization, J. Antibiot. 29, 10–14.
Cheng, X.C., Jensen, P.R., and Fenical, W. (1999) Arenaric Acid, a New Pentacyclic Polyether Produced by a Marine Bacterium (Actinomycetales), J. Nat. Prod. 62, 605–607.
Sassaki, T. (1985) A New Antibiotic SF2324 Produced by Actinomadura, Japanese Patent Application 60130394.
Sezaki, M., Sasaki, T., Nakazawa, T., Takeda, U., Iwata, M., Watanabe, T., Koyama, M., Kai, F., Shomura, T., and Kojima, M. (1985) A New Antibiotic SF-2370 Produced by Actinomadura, J. Antibiot. 38, 1437–1439.
Labeda, D.P., Goodman, J.J., and Martin, J.H.E.J. (1986) Antibiotic LL-C23201-γ, U.S. Patent Application 4628046.
Bull, A.T., Goodfellow, M., and Slater, J.H. (1992) Biodiversity as a Source of Innovation in Biotechnology, Annu. Rev. Microbiol. 46, 219–246.
Dirlam, J.P., Belton, A.M., Bordner, J., Cullen, W.P., Huang, L.H., Kojima, Y., Maeda, H., Nishiyama, S., Oscarson, J.R., Ricketts, A.P., et al. (1992) CP-82,009, a Potent Polyether Anticoccidial Related to Septamycin and Produced by Actinomadura sp., J. Antibiot. 45, 331–340.
Wright, D.E. (1979) The Oorthosomycins, a New Family of Antibiotics, Tetrahedron 35, 1207–1237.
Girijavallabhan, V.M., and Ganguly, A.K. (1992) Antibiotics, in Kirk-Othmer Encyclopedia of Chemical Technology, 4th edn., Vol. 3, pp. 259–266, John Wiley & Sons, New York.
Ganguly, A.K., and Saksena, A.K. (1975) Structure of Everninomicin B, J. Antibiot. 28, 707–709.
Ganguly, A.K., Sarre, O.Z., Greeves, D., and Morton, J. (1975) Structure of Everninomicin D-1, J. Am. Chem. Soc. 97, 1982–1985.
Ganguly, A.K., Pramanik, B., Chan, T.M., Sarre, O.Z., Liu, Y.-T., Morton, J., and Girijavallabhan, V. (1989) The Structure of New Oligosaccharide Antibiotics, 13–384 Component-1 and Component-5, Heterocycles 28, 83–88.
Wang, E., Simard, M., Bergeron, Y., Beauchamp, D., and Bergeron, M.G. (2000) In vivo Activity and Pharmacokinetics of Ziracin (SCH27899), a New Long-Acting Everninomicin Antibiotic, in a Murine Model of Penicillin-Susceptible or Penicillin-Resistant Pneumococcal Pneumonia, Antimicrob. Agents Chemother. 44, 1010–1018.
Linden, P.K., and Miller, C.B. (1999) Vancomycin Resistant Enterococci: The Clinical Effect of a Common Nosocomial Pathogen, Diagnost. Microbiol. Infect. Disease 33, 113–120.
Chu, M., Mierza, R., Patel, M., Jenkins, J., Das, P., Pramanik, B., and Chan, T.-M. (2000) A Novel Everminomicin Antibiotic Active Against Multidrug-Resistant Bacteria, Tetrahedron Lett. 41, 6689–6693.
Saksena, A.K., Jao, E., Murphy, B., Schumacher, D., Chan, T.M., Puar, M.S., Jenkins, J.K., Maloney, D., Cordero, M., Pramanik, B.N., et al. (1998) Structure Elucidation of Sch 49088, a Novel Everninomicin Antibiotic Containing an Unusual Hydroxylamino-Ether Sugar, Everhydroxylaminose, Tetrahedron Lett. 39, 8441–8444.
Bartner, P., Pramanik, B.N., Saksena, A.K., Liu, Y.-H., Das, P.R., Sarre, O., and Ganguly, A.K. (1997) Structure Elucidation of Everninomicin-6, a New Oligosaccharide Antibiotic, by Chemical Degradation and FAB-MS Methods, J. Am. Soc. Mass Spectrom. 8, 1134–1140.
Liu, C.M., Hermann, T.E., Downey, A., La, B., Prosser, T., Schildknecht, E., Palleroni, N.J., Westley, J.W., and Miller, P.A. (1983) Novel Polyether Antibiotics X-14868A, B, C, and D Produced by a Nocardia. Discovery, Fermentation, Biological as well as Ionophore Properties and Taxonomy of the Producing Culture, J. Antibiot. 36, 343–350.
Liu, C.M., Prosser, T., and Westley, J. (1985) Antibiotic X-14934A, U.S. Patent Application 4,510,317.
Cullen, W.P., Bordner, J., Huang, L.H., Moshier, P.M., Oscarson, J.R., Presseau, L.A., Ware, R.S., Whipple, E.B., Kojima, Y., and Maeda, H. (1990) CP-60,993, a New Dianemycin-like Ionophore Produced by Streptomyces hygroscopicus ATCC 39305: Fermentation, Isolation and Characterization, J. Ind. Microbiol. 5, 365–374.
Celmer, W.D., Cullen, W.P., Maeda, H., Ruddock, J.C., and Tone, J. (1987) 19-Epi-dianemycin as an Anticoccidial and Antibacterial Agent, U.S. Patent Application 4707493.
Oscarson, J.R., Bordner, J., Celmer, W.D., Cullen, W.P., Huang, L.H., Maeda, H., Moshier, P.M., Nishiyama, S., Presseau, L., Shibakawa, R., and Tone, J. (1989) Endusamycin, a Novel Polycyclic Ether Antibiotic Produced by a Strain of Streptomyces endus subsp. aureus, J. Antibiot. 42, 37–48.
Dirlam, J.P., Presseau-Linabury, L., and Koss D.A. (1990) The Structure of CP-80,219, a New Polyether Antibiotic Related to Dianemycin, J. Antibiot. 43, 727–730.
Nakayama, H., Seto, H., Otake, N., Yamaguchi, M., Kawashima, A., Mizutani, T., and Omura, S. (1985) Studies on the Ionophorous Antibiotics. 28. Moyukamycin, a New Glycosylated Polyether Antibiotic, J. Antibiot. 38, 1433–1436.
Westley, J.W., Liu, C.M., Sello, L.H., Troupe, N., Blount, J.F., Chiu, A.M., Todaro, L.J., Miller, P.A., and Liu, M. (1984) Isolation and Characterization of Antibiotic X-14931A, the Naturally Occurring 19-Deoxyaglycone of Dianemycin, J. Antibiot. 37, 813–815.
Hauske, J.R., and Kostek, G. (1989) Structure Elucidation of a New Polyether Antibiotic iso-Dianemycin, J. Org. Chem. 54, 3500–3504.
Kawada, M., Sumi, S., Umezawa, K., Inouye, S., Sawa, T., and Seto, H. (1992) Circumvention of Multidrug Resistance in Human Carcinoma KB Cells by Polyether Antibiotics, J. Antibiot. 45, 556–562.
Dirlam, J.P., Belton, A.M., Bordner, J., Cullen, W.P., Huang, L.H., Kojiima, Y., Maeda, H., Hishida, H., Nishiyama, S., Oscarson, J.R., Rickets, A.P., Sakakibara, T., Tone, J., and Tsukuda, K. (1990) CP-84,657, a Potent Polyether Anticocidial Related to Portmicin and Produced by Actinomadura sp., J. Antibiot. 43, 668–679.
Ricketts, A.P., Dirlam, J.P., and Shively, J.E. (1992) Anticocidial Efficacy and Chicken Toleration of Potent New Polyether Ionophores. 2. The Portmicin Relative CP-84,657, Poultry Sci. 71, 1631–1636.
Dirlam, J.P., Bordner, J., Chang, S.P., Grizzuti, A., Nelson, H., Tynan, E.J., and Whipple, E.B. (1992) The Isolation and Structure of CP-120,509, a New Polyether Antibiotic Related to Semduramicin and Produced by Mutants of Actinomadura roseorufa, J. Antibiot. 45, 1544–1548.
Kusakabe, Y., Mitsuoka, S., Omuro, Y., Seino, A., Arika, T., and Iwakaya, Y. (1979) Antibiotic of CP-120,509, Japanese Patent Application 7984576.
Cullen, W.P., Celmer, W.D., Chappel, L.R., Huang, L.H., Jefferson, M.T., Ishiguro, M., Maeda, H., Nishiyama, S., Oscarson, J.R., Shibakawa, R., and Tone, J. (1988) CP-61,405, a Novel Polycyclic Pyrrolether Antibiotic Produced by Streptomyces routienii huang sp. nov., J. Industr. Microbiol. 2, 349–357.
Glazer, E.A., Koss, D.A., Olson, J.A., Ricketts, A.P., Schaaf, T.K., and Wiscount, R.J., Jr. (1992) Synthetic Modification of a Novel Microbial Ionophore—Exploration of Anticoccidial Structure-Activity Relationships, J. Med. Chem. 35, 1839–1844.
Ricketts, A.P., Glazer, E.A., Migaki, T.T., and Olson, J.A. (1992) Anticoccidial Efficacy of Semduramicin in Battery Studies with Laboratory Isolates of Coccidia, Poultry Sci. 71, 98–103.
Tynan, E.J., Nelson, T.H., Davies, R.A., and Wernau, W.C. (1992) The Production of Semduramicin by Direct Fermentation, J. Antibiot. 45, 813–815.
Dobler, M. (1981) Ionophores and Their Structures, p. 379, John Wiley & Sons, New York.
Mulhaupt, T. (2003). Isolierung and Strukturafklarung von Sekundarmetaboliten aus marinen Microorganismen nach biologischen und chemischen Gesichspunkten, Ph.D. Dissertation, Ludwig-Maximilians Universitat, Munchen, Germany.
Sun, Y. Zhou, X., Liu, J., Bao, K., Zhang, G., Tu, G., Kieser, T., and Deng, Z. (2002) Streptomyces nanchangensis, a Producer of the Insecticidal Polyether Antibiotic Nanchangmycin and the Antiparasitic Macrolide Meilingmycin, Contains Multiple Polyketide Gene Clusters, Microbiology 148, 361–371.
Sun, Y.H., Zhou, X.F., Tu, G.Q., and Deng, Z.X. (2002) Determination of Nanchangmycin and Meilingmycin by High Performance Liquid Chromatography, Se Pu (in Chinese) 20, 43–45.
Sun, Y., Zhou, X., Dong, H., Tu, G., Wang, M., Wang, B., and Deng, Z. (2003) A Complete Gene Cluster from Streptomyces nanchangensis NS3226 Encoding Biosynthesis of the Polyether Ionophore Nanchangmycin, Chem. Biol. 10, 431–441.
Konishi, M., Yang, X., Li, B., Fairchild, C.R., and Shimizu, Y. (2004) Highly Cytotoxic Metabolites from the Culture Supernatant of the Temperate Dinoflagellate Protoceratium cf. reticulatum, J. Nat. Prod. 67, 1309–1313.
Graneli, E., and Johansson, N. (2003) Increase in the Production of Allelopathic Substances by Prymnesium parvum Cells Grown Under N- or P-Deficient Conditions, Harmful Algae 2, 135–145.
Yasumoto, T. (2001) The Chemistry and Biological Function of Natural Marine Toxins, Chem. Rec. 1, 228–242.
Igarashi, T., Satake, M., and Yasumoto, T. (1996) Prymnesin-2: A Potent Ichthyotoxic and Hemolytic Glycoside Isolated from the Red Tide Alga Prymnesium parvum, J. Am. Chem. Soc. 118, 479–480.
Igarashi, T., Satake, M., and Yasumoto, T. (1999) Structures and Partial Stereochemical Assignments for Prymnesin-1 and Pyrmnesin-2: Potent Hemolytic and Ichthyotoxic Glycosides Isolated from the Red Tide Alga Prymnesium parvum, J. Am. Chem. Soc. 121, 8499–8511.
Igarashi, T., Aritake, S., and Yasumoto, T. (1998) Biological Activities of Prymnesin-2 Isolated from a Red Tide Alga Prymnesium parvum, Nat. Toxins, 6, 35–41.
Hamilton-Miller, J.M.T. (1973) Chemistry and Biology of the Polyene Macrolide Antibiotics, Bacteriol. Rev. 37, 166–196.
Fenical, W. (1993) Chemical Studies of Marine Bacteria: Develo** a New Resource, Chem. Rev. 93, 1673–1683.
Keseru, G.M., and di Nogra, M. (1995) The Chemistry of Natural Diarylheptanoids, in Studies in Natural Products Chemistry (Atta-ur-Rahman, ed.) Vol. 17, pp. 357–394, Elsevier Science, New York.
Roughley, P.J., and Whiting, D.A. (1971) Diarylheptanoids: The Problems of the Biosynthesis, Tetrahedron Lett., 3741–3746.
Roughley, P.J., and Whiting, D.A. (1973) Experiments in the Biosynthesis of Curcumin, J. Chem. Soc., Perkin Trans 1, 2379–2388.
Inoue, T., Kenmochi, N., Furukawa, N., and Fujita, M. (1987) Biosynthesis of Acerogenin A, a Diarylheptanoid from Acer nikoense, Phytochemistry 26, 1409–1411.
Inoue, T. (1993) Constituents of Acer nikoense and Myrica rubra. On Diarylheptanoids, Yakugaku Zasshi (in Japanese) 113, 181–197.
Morikawa, T., Tao, J., Toguchida, I., Matsuda, H., and Yoshikawa, M. (2003) Structures of New Cyclic Diarylheptanoids and Inhibitors of Nitric Oxide Production from Japanese Folk Medicine Acer nikoense, J. Nat. Prod. 66, 86–91.
Matsuda, H., Morikawa, T., Tao, J., Ueda, K., and Yoshikawa, M. (2002) Bioactive Constituents of Chinese Natural Medicines. VII. Inhibitors of Degranulation in RBL-2H3 Cells and Absolute Stereostructures of Three New Diarylheptanoid Glycosides from the Bark of Myrica rubra, Chem. Pharm. Bull. 50, 208–215.
Tao, J., Morikawa, M., Toguchida, I., Ando, S., Matsuda, H., and Yoshikawa, M. (2002) Inhibitors of Nitric Oxide Production from the Bark of Myrica rubra: Structures of New Biphenyl Type Diarylheptanoid Glycosides and Taraxerane Type Triterpene, Bioorg. Med. Chem. 10, 4005–4012.
Lakshmi Niranjan Reddy, V., Ravinder, K., Srinivasulu, M., Venkateshwar Goud, T., Malla Reddy, S., Srujankumar, D., Prabhakar Rao, T., Suryanarayana Murty, U., and Venkateswarlu, Y. (2003) Two New Macrocyclic Diaryl Ether Heptanoids from Boswellia ovalifoliolata, Chem. Pharm. Bull. 51, 1081–1084.
Arcamone, F.M., Bertazolli, C., Ghione, M., and Scotti, T. (1959) Melanosporin and Elaiophylin, New Antibiotics from Streptomyces melanosporus (Sive melanosporofaciens) sp., Gion. Microbiol. 7, 207–216.
Arai, M. (1960) Azalomycins B and F, Two New Antibiotics II. Properties and Isolation, J. Antibiot. 13, 46–50.
Fiedler, H.P., Worner, W., Zahner, H., Kaiser, H.P., Keller-Schierlein, W., and Muller, A. (1981) Metabolic Products of Microorganisms. 200. Isolation and Characterisation of Niphithricins A and B, and Elaiophylin, Antibiotics Produced by Streptomyces violaceoniger, J. Antibiot. 34, 1107–1118.
Haydock, S.F., Mironenko, T., Ghoorahoo, H.I., and Leadlay, P.F. (2004) The Putative Elaiophylin Biosynthetic Gene Cluster in Streptomyces sp. DSM4137 Is Adjacent to Genes Encoding Adenosylcobalamin-Dependent Methylmalonyl CoA Mutase and to Genes for Synthesis of Cobalamin, J. Biotechnol. 113, 55–68.
Yamada, T., Minoura, K., and Numata, A. (2002) Halichoblelide, a Potent Cytotoxic Macrolide from a Streptomyces Species Separated from a Marine Fish, Tetrahedron Lett. 43, 1721–1724.
Erickson, K.L., Gustafson, K.R., Pannell, L.K., Beutler, J.A., and Boyd, M.R. (2002) New Dimeric Macrolide Glycosides from the Marine Sponge Myriastra clavosa, J. Nat. Prod. 65, 1303–1306.
Rao, M.R., and Faulkner, D.J. (2002) Clavosolides A and B, Dimeric Macrolides from the Philippines Sponge Myriastra clavosa, J. Nat. Prod. 65, 386–388.
Luo, Y., Feng, C., Tian, Y., and Zhang, G. (2002) Glycosides from Dicliptera riparia, Phytochemistry 61, 449–454.
Hamburger, M., Hostettmann, M., Stoeckli-Evans, H., Solis, P.N., Gupta, M.P., and Hostettmann, K. (1990) A Novel Type of Dimeric Secoiridoid Glycoside from Lisianthius jefensis Robyns et Elias, Chim. Acta 73, 1845–1852.
Mukhtara, N., Malik, A., Riaza, N., Iqbala, K., Tareen, R.B., Khana, S.N., Nawaza, S.A., Siddiquia, J., and Iqbal Choudharya, M.I. (2004) Pakistolides A and B, Novel Enzyme Inhibitory and Antioxidant Dimeric 4-(Glucosyloxy)benzoates from Berchemia pakistanica, Helv. Chim. Acta 87, 416–424.
Inoshiri, S., Sasaki, M., Kohda, H., Otsuka, H., and Yamasaki, K. (1987) Aromatic Glycosides from Berchemia racemosa, Phytochemistry 26, 2811–2814.
Okuda, T., Yoshida, T., and Hatano, T. (1993) Classification of Oligomeric Hydrolysable Tannins and Specificity of Their Occurrence in Plants, Phytochemistry 32, 507–521.
Yoshida, T., Hatano, T., and Ito, H. (2000) Chemistry and Function of Vegetable Polyphenols with High Molecular Weights, Biofactors 13, 121–125.
Chen, L.-G., Yen, K.-Y., Yang, L.-L., Hatano, T., Okuda, T., and Yoshida, T. (1999) Macrocyclic Ellagitannin Dimers, Cuphiins D1 and D2, and Accompanying Tannins from Cuphea hyssopifolia, Phytochemistry 50, 307–312.
Lee, M.H., Chiou, J.F., Yen, K.Y., Yang, L.L., Yen, K.Y., Hatano, T., Yoshida, T., and Okuda, T. (1997) Two Macrocyclic Hydrolysable Tannin Dimers from Eugenia uniflora, Phytochemistry 44, 1343–1349.
Yoshida, T., Chou, T., Shing, T., and Okuta, T. (1995) Oenotheins D, F and G, Hydrolysable Tannin Dimers from Oenothera laciniata, Phytochemistry 40, 565–561.
Yoshida, T., Chou, T., Haba, K., Okano, Y., Shingu, T., Miyamoto, K., Koshiura, R., and Okuda, T. (1989) Camelliin B and Nobotanin I, Macrocyclic Ellagitannin Dimers and Related Dimers, and Their Antitumor Activity, Chem. Pharm. Bull. 37, 3174–3176.
Yoshida, T., Chou, T., Matsuda, M., Yasuhara, T., Yazaki, K., Hatano, T., Nitta, A., and Okuda, T. (1991) Woodfordin D and Oenothein A, Trimeric Hydrolyzable Tannins of Macro-Ring Structure with Antitumor Activity, Chem. Pharm. Bull. (Tokyo) 39, 1157–1162.
Wang, C.C., Chen, L.G., and Yang, L.L. (1999) Antitumor Activity of Four Macrocyclic Ellagitannins from Cuphea hyssopifolia, Cancer Lett. 140, 195–200.
Wang, C.C., Chen, L.G., and Yang, L.L. (2000) Cuphiin D1, the Macrocyclic Hydrolyzable Tannin Induced Apoptosis in HL-60 Cell Line, Cancer Lett. 149, 77–83.
Qian-Cutrone, J., Ueki, T., Huang, S., Mookhtiar, K.A., Ezekiel, R., Kalinowski, S.S., Brown, K.S., Golik, J., Lowe, S., Pirnik, D.M., et al. (1999) Glucolipsin A and B, Two New Glucokinase Activators Produced by Streptomyces purpurogeniscleroticus and Nocardia vaccinii, J. Antibiot.52, 245–255.
Habib, E.S., Yokomizo, K., Suzuki, K., and Uyeda, M. (2001) Biosynthesis of Fattiviracin FV-8, an Antiviral Agent, Biosci. Biotechnol. Biochem. 65, 861–864.
Habib, E.S., Yokomizo, K., Nagao, K., Harada, S., and Uyeda, M. (2001) Antiviral Aactivity of Fattiviracin FV-8 Against Human Immunodeficiency Virus Type 1 (HIV-1), Biosci. Biotechnol. Biochem. 65, 683–685.
Tsunakawa, M., Komiyama, N., Tenmyo, O., Tomita, K., Kawano, K., Kotake, C., Konishi, M., and Oki, T. (1992) New Antiviral Antibiotics, Cycloviracins B1 and B2. I. Production, Isolation, Physico-chemical Properties and Biological Activity, J. Antibiot.45, 1467–1471.
Tsunakawa, M., Kotake, C., Yamasaki, T., Moriyama, T., Konishi, M., and Oki, T. (1992) New Antiviral Antibiotics, Cycloviracins B1 and B2. II. Structure Determination, J. Antibiot. 45, 1472–1480.
Uyeda, M., Yokomizo, K., Miyamoto, Y., and Habib, E.E. (1998) Fattiviracin A1, a Novel Antiherpetic Agent Produced by Streptomyces microflavus Strain No. 2445. I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Structure Elucidation, J. Antibiot. 51, 823–828.
Yokomizo, K., Miyamoto, Y., Nagao, K., Kumagae, E., Habib, E.S., Suzuki, K., Harada, S., and Uyeda, M. (1998) Fattiviracin A1, a Novel Antiviral Agent Produced by Streptomyces microflavus Strain No. 2445. II. Biological Properties, J. Antibiot. 51, 1035–1039.
Hyodo, T., Tsuchiya, Y., Sekine, A., and Amano, T. (1999) A Novel Antiviral Agent Produced by Streptomyces, Japanese Kokai Tokkyo Koho, Japanese Patent Application 11246587.
Takahashi, S., Hosoya, M., Koshino, H., and Nakata, T. (2003) Determination of Absolute Structure of Macroviracins by Chemical Synthesis, Org. Lett. 5, 1555–1558.
Kaneko, T., Sakamoto, M., Ohtani, K., Ito, A., Kasai, R., Yamasaki, K., and Padorina, W.G. (1995) Secoiridoid and Flavonoid Glycosides from Gonocaryum calleryanum, Phytochemistry 39, 115–120.
Mabberley, D.J. (1997) The Plants-Book, a Portable Dictionary of the Vascular Plants, Oxford University Press, Oxford.
Chan, Y.Y., Leu, Y.L., Lin, F.W., Li, C.Y., Wu, Y.C., Shi, L.S., Liou, M.J., and Wu, T.S. (1998) A Secoiridoid and Other Constituents of Gonocaryum calleryanum, Phytochemistry 47, 1073–1077.
Jansen, R., Kunze, B., Reichenbach, H., and Höfle, G. (2000) Antibiotics from Gliding Bacteria, LXXXVI. Apicularen A and B, Cytotoxic 10-Membered Lactones with a Novel Mechanism of Action from Chondromyces Species (Myxobacteria): Isolation, Structure Elucidation, and Biosynthesis, Eur. J. Org. Chem. 6, 913–919.
Kunze, B., Jansen, R., Sasse, F., Hofle, G., and Reichenbach, H. (1998) Apicularens A and B, New Cytostatic Macrolides from Chondromyces Species (Myxobacteria): Production, Physico-chemical and Biological Properties, J. Antibiot. 51, 1075–1080.
Rezanka, T., and Dembitsky, V.M. (2003) Ten Membered Substituted Cyclic 2-Oxecanone (decalactone) Derivatives from Latrunculia corticata, a Red Sea Sponge, Eur. J. Org. Chem., 2144–2152.
Fogliani, B., Raharivelomanana, P., Bianchini, J.-P., Bouraïma-Madjèbi, S., and Hnawia, E. (2005) Bioactive Ellagitannins from Cunonia macrophylla, an Endemic Cunoniaceae from New Caledonia, Phytochemistry 66, 241–247.
Latté, K.P., and Kolodziej, H. (2000) Pelargoniins, New Ellagitannins from Pelargonium reniforme, Phytochemistry 54, 701–708.
Niemetz, R., Schilling, G., and Gross, G.G. (2003) Biosynthesis of the Dimeric Ellagitannin, Cornusiin E, in Tellima grandiflora, Phytochemistry 64, 109–114.
Seeram, N., Lee, R., Hardy, M., and Heber, D. (2005) Rapid Large Scale Purification of Ellagitannins from Pomegranate Husk, a By-product of the Commercial Juice Industry, Separat. Purific. Technol. 41, 49–55.
Park, E.K., Kim, M.S., Lee, S.H., Kim, K.H., Park, J.-Y., Kim, T.-H., Lee, I.-S., Woo, J.-T., Jung, J.-C., Shin, H.-I., et al. (2004) Furosin, an Ellagitannin, Suppresses RANKL-Induced Osteoclast Differentiation and Function Through Inhibition of MAP Kinase Activation and Actin Ring Formation, Biochem. Biophys. Res. Commun. 325, 1472–1480.
Notka, F., Meier, G., and Wagner, R. (2004) Concerted Inhibitory Activities of Phyllanthus amarus on HIV Replication in vitro and ex vivo, Antiviral Res. 64, 93–102.
Martino, V., Morales, J., Martínez-Irujo, J.J., Font, M., Monge, A., and Coussio, J. (2004) Two Ellagitannins from the Leaves of Terminalia triflora with Inhibitory Activity on HIV-1 Reverse Transcriptase, Phytother. Res. 18, 667–669.
Dutcher, J.D. (1963) Chemistry of the Amino Sugars Derived from Antibiotic Substances, Adv. Carbohydr. Chem. 18, 259–308.
Djerassi, C., and Halpern, O. (1957) The Structure of the Antibiotic Neomethymycin, J. Am. Chem. Soc. 79, 2022–2023.
Djerassi, C., and Halpern, O. (1958) Macrolide Antibiotics. VII. The Structure of Neomethymycin, Tetrahedron 3, 255–268.
Hong, J.S.J., Park, S.H., Choi, C.Y., Sohng, J.K., and Yoon, Y.J. (2004) New Olivosyl Derivatives of Methymycin/Pikromycin from an Engineered Strain of Streptomyces venezuelae, FEMS Microbiol. Lett. 238, 391–399.
Mertz, F.P., and Yao, R.C. (1990) Saccharopolyspora spinosa sp. nov. Isolated from Soil Collected in a Sugar Mill Rum Still, Int. J. Syst. Bacteriol. 40, 34–39.
Kirst, H.A., Michel, K.H., Martin, J.W., Creemer, L.C., Chio, E.H., Yao, R.C., Nakatsukasa, W.M., Boeck, L., Occolowitz, J.L., Paschal, J.W. et al. (1991) A83543A-D, Unique Fermentation Derived Tetracyclic Macrolides, Tetrahedron Lett. 32, 4839–4842.
De Amicis, C.V., Dripps, J.E., Hatten, C.J., and Karr, L. (1997) Physical and Biological Properties of the Spynosins: Novel Macrolide Pest-Control Agents from Fermentation, in Phytochemicals for Pest Control (Hedin, P.A., Hollingworth, R.M., Masler, E.P., Miyamoto, J., and Thompson, D.G., eds.), ACS Symposium Series 658, pp. 144–154, American Chemical Society, Washington, DC.
Kirst, H.A., Michel, K.H., Mynderse, J.S., Chio, E.H., Yao, R.C., Nakatsukasa, W.M., Boeck L., Occolowitz, J.L., Paschal, J.W., Deeter, J.B., and Thompson, G.D. (1992) Discovery, Isolation, and Structure Elucidation of a Family of Structurally Unique Fermentation Derived Tetracyclic Macrolides, in Synthesis and Chemistry of Agrochemicals III (Baker, D.R., Fenyes, J.G., and Stevens, J.J., eds.), pp. 214–225, American Chemical Society, Washington, DC.
Sparks, T.C., Crouse, G.D., and Durst, G. (2001) Natural Products as Insecticides: The Biology, Biochemistry, and Quantitative Structure-Activity Relationships of Spinosyns and Spinosoids, Pest Management Sci. 57, 896–905.
Sparks, T.C., Thompson, G.D., Kirst, H.A., Hertline, M.B., Larson, L.L., Worden, T.V., and Thibault, S.T. (1998) Biological Activity of the Spinosyns, New Fermentation Derived Insect Control Agents, on Tobacco Budworm (Lepidoptera, Noctuidae) Larvae, J. Econ. Entomol. 91, 1277–1283.
Thompson, G.D., Dutton, R., and Sparks, T.C. (2000) Spinosad—A Case Study: An Example from a Natural Products Discovery Programme, Pest Management Sci. 56, 696–702.
Waldron, C., Matsushima, P., Rosteck, P.R., Jr., Broughton, M.C., Turner, J., Madduri, K., Crawford, K.P., Merlo, D.J., and Baltz, R.H. (2001) Cloning and Analysis of the Spinosad Biosynthetic Gene Cluster of Saccharopolyspora spinosa, Chem. Biol. 8, 487–499.
Gaisser, S., Martin, C.J., Wilkinson, B., Sheridan, R.M., Lill, R.E., Weston, A.J., Ready, S.J., Waldron, C., Crouse, G.D., Leadlay, P.F., and Staunton, J. (2002) Engineered Biosynthesis of Novel Spinosyns Bearing Altered Deoxyhexose Substituents, Chem. Commun., 618–619.
Boeck, L., Chio, H., Eaton, T., Godfrey, O., Michel, K., Nakatsukasa, W., and Yao, R. (Eli Lilly). (1990) Lepicidin A from the Soil Microbe Saccharopolyspora spinosa, European Patent Application EP375 316; Chem. Abstr. 114, 80066 (1991).
Sone, H., Kigoshi, H., and Yamada, K. (1996) Aurisides A and B, Cytotoxic Macrolide Glycosides from the Japanese Sea Hare Dolabella auricularia, J. Org. Chem. 61, 8956–8960.
Tan, L.T., Marquez, B.L., and Gerwick, W.H. (2002) Lyngbouilloside, a Novel Glycosidic Macrolide from the Marine Cyanobacterium Lyngbya bouillonii, J. Nat. Prod. 65, 925–928.
Luesch, H., Yoshida, W.Y., Harrigan, G.G., Doom, J.P., Moore, R.E., and Paul, V.J. (2002) Lyngbyaloside B, a New Glycoside Macrolide from a Palauana Marine Cyanobacterium, Lyngbya sp., J. Nat. Prod. 65, 1945–1948.
Zampella, A., D'Auria, M.V., and Minale, L. (1997) Callipeltosides B and C, Two Novel Cytotoxic Glycoside Macrolides from a Marine Lithistida Sponge Callipelta sp., Tetrahedron 53, 3243–3248.
Zampella, A., D'Auria, M.V., Minale, L., Debitus, C., and Roussakis, C. (1996) Callipeltoside A: A Cytotoxic Aminodeoxy Sugar-Containing Macrolide of a New Type from the Marine Lithistida Sponge Callipelta sp., J. Am. Chem. Soc. 118, 11085–11088.
Yotsu-Yamada, M., Haddock, R.L., and Yasumoto, T. (1993) Polycavernoside A—A Novel Glycosidic Macrolide from the Red Alga Polycavernosa tsudai (Gracilaria edulis), J. Am. Chem. Soc. 115, 1147–1148.
Yotsu-Yamada, M., Seki, T., Paul, V., Hideo, H., and Yasumoto, T. (1995) 4 New Analogs of Polycavernoside A, Tetrahedron Lett. 36, 5563–5566.
Momose, I., Iinuma, H., Kinoshita, N., Momose, Y., Kunimoto, S., Hamada, M., and Takeuchi, T. (1999) Decatromicins A and B, New Antibiotics Produced by Actinomadura sp. MK73-NF4. I. Taxonomy, Isolation, Physico-chemical Properties and Biological Activities, J. Antibiot. 52, 781–786.
Momose, I., Hirosawa, S., Nakamura, H., Naganawa, H., Iinuma, H., Ikeda, D., and Takeuchi, T. (1999) Decatromicins A and B, New Antibiotics Produced by Actinomadura sp. MK73-NF4. II. Structure Determination, J. Antibiot. 52, 787–796.
Schroeder, D.R., Colson, K.L., Klohr, S.E., Lee, M.S., Matson, J.A., Brinen, L.S., and Clardy, J. (1996) Pyrrolosporin A, a New Antitumor Antibiotic from Micromonospora sp. C39217-R109-7. 2. Isolation, Physico-chemical Properties, Spectroscopic Study and X-Ray Analysis, J. Antibiot. 49, 865–872.
Lam, K.S., Hesler, G.A., Gustavson, D.R., Berry, R.L., Tomita, K., MacBeth, J.L., Ross, J., Miller, D., and Forenza, S. (1996) Pyrrolosporin A, a New Antitumor Antibiotic from Micromonospora sp. C39217-R109-7. 1. Taxonomy of Producing Organism, Fermentation and Biological Activity, J. Antibiot. 49, 860–864.
McGuire, J.M., Bunch, R.L., Anderson, R.C., Doaz, H.E., Flyun, E.H., Powell, H.M., and Smith, J.W., (1952) Ilotycin, a New Antibiotic, Schweiz. Med. Wochenschr. 82, 1064–1065.
Wiley, P.F., Gale, R., Pettinga, C.W., and Gerzon, K. (1957) Erythromycin. XII. The Isolation, Properties and Partial Structure of Erythromycin C, J. Am. Chem. Soc. 79, 6074–6077.
Maier, J., Martin, J.R., Egan, R.S., and Corcoran, J.W. (1977) Antibiotic Glycosides. 8. Erythromycin D, a New Macrolide Antibiotic, J. Am. Chem. Soc. 99, 1620–1622.
Martin, J.R., Devault, R.L., Sinclair, A.C., Stanaszek, R.S., and Johnson, P. (1982) A New Naturally Occurring Erythromycin: Erythromycin F, J. Antibiot. 35, 426–430.
Cachet, T., Roets, E., Hoogmartens, J., and Van Der Haeghe, H. (1975) Extension of the Erythromycin Biosynthetic Pathway: Isolation and Structure of Erythromycin E, Tetrahedron 31, 1985–1989.
Celmer, W.D., and Sobin, B.A. (1956) The Isolation of Two Synergistic Antibiotics from a Single Fermentation Source, Antibiot. Annu. 1955–1956, 437–441.
Celmer, W.D., Els, H., and Murai, K. (1958) Oleandomycin Derivatives, Preparation and Characterization, Antibiot. Ann. 1957–1958, 476–483.
Celmer, W.D. (1971) Stereochemical Problems in Macrolide Antibiotics, Pure Appl. Chem. 28, 413–453.
Brockmann, H. (1963) Anthracyclinones and Anthracyclines (rhodomycinone, pyrromycinone and their glycosides), Fortschr. Chem. Org. Naturst. (in German) 21, 121–182.
Brockmann, H., and Pfennig, N. (1953) The Production of Actinomycin by Counter Current Partition, Hoppe Seylers Z. Physiol. Chem. 292, 77–88.
Corbaz, R., Ettlinger, L., Kellerschierlein, W., and Zahner, H. (1957) Systematology of Actinomycetes. I. Streptomycetes with Rhodomycin-like Pigments, Arch. Mikrobiol. (in German) 25, 325–332.
Majer, J., McAlpine, J.B., Egan, R.S., and Corcoran, J.W. (1976) Antibiotic Glycosides. VII 10,11-Dihydropicromycin: Another Metabolite of Streptomyces venezuelae, J. Antibiot. 29, 769–770.
Stephens, V.C., Conine, J.W., and Murphy, H.W. (1959) Esters of Erythromycin. IV. Alkyl Sulfate Salts, J. Am. Pharm. Assoc. 48, 620–622.
Stephens, V.C., and Conine, J.W. (1959) Esters of Erythromycin. III. Esters of Low Molecular Weight Aliphatic Acids, Antibiot Annu. 1958–1959, 346–353.
Clark, R.K., Jr., Fricke, H.H., and Lanius, B. (1957) The Purification of Synnematin B by Ion Exchange Resins, Antibiot. Annu. 1956–1957, 749–754.
Philippon, A., Cluzel, R., and Soussy, C.J. (1995) Azithromycin: Critical Points, Pathol Biol (Paris) (in French) 43, 488–497.
Marquez, J., Murawski, A., Wagman, G.H., Jaret, R.S., and Reimann, H. (1969) Isolation, Purification and Preliminary Characterization of Megalomicin, J. Antibiot. 22, 259–264.
Takasawa, S., Kawamoto, I., Okachi, R., Machida, Y., and Nara, T. (1974) A New Antibiotic, XK-46, J. Antibiot. 27, 502–506.
Wagman, G.H., and Weistein, M.J. (1980) Antibiotic from Micromonospora, Annu. Rev. Microbiol. 34, 537–557.
Egan, R.S., and Martin, J.R. (1970) Structure of Lankamycin, J. Am. Chem. Soc. 92, 4129–4130.
Muntwyler, R., and Keller-Schierlein, W. (1972) Metabolic Products of Microorganisms. Stereochemistry of Lankamycin, Helv. Chim. Acta (in German) 55, 460–467.
Roncari, G., and Keller-Schierlein, W. (1966) Metabolic Products of Microorganisms, Helv. Chim. Acta (in German) 49, 705–711.
Namiki, S., Omura, S., Nakayoshi, H., and Sawada, J. (1969) Studies on the Antibiotics from Streptomyces spinichromogenes var. kujimyceticus. I. Taxonomic and Fermentation Studies with Streptomyces spinichromogenes var. kujimyceticus, J. Antibiot. 22, 494–499.
Omura, S., Muro, T., Namiki, S., Shibata, M., Sawada, J. and (1969) Studies on the Antibiotics from Streptomyces spinichromogenes var. kujimyceticus. 3. The Structure of Kujimycin A and Kujimycin B, J. Antibiot. 22, 629–634.
Martin, J.R., Egan, R.S., Goldstein, A.W., Mueller, S.L., Kellerschierlein, W., Mitscher, L.A., and Foltz, R.L. (1976) 3′-De-O-methyl-2′,3′-anhydro-lankamycin, A New Macrolide Antibiotic from Streptomyces violaceoniger, Helv. Chim. Acta. 59, 1886–1894.
Martin, J.R., Egan, R.S., Goldstein, A.W., Stanaszek, R.S., Tadanier, J., and Kellerschierlein, W. (1977) Minor Lankamycin-Related Antibiotics from Streptomyces violaceoniger, Helv. Chim. Acta 60, 2559–2565.
Arnoux, B., Pascard, C., Raynaud, L., and Lunel, J. (1980) 23672 RP, a New Macrolide Antibiotic from Streptomyces chryseus. Mass Spectrometry Study and X-Ray Structure Determination, J. Am. Chem. Soc. 102, 3605–3608.
Klein, D., Braekman, J.C., Daloze, D., Hoffmann, L., and Demoulin, V. (1997) Lyngbyaloside, a Novel 2,3,4-Tri-O-methyl-6-deoxy-α-mannopyranoside Macrolide from Lyngbya bouillonii (Cyanobacteria), J. Nat. Prod. 60, 1057–1059.
Hegde, V.R., Patel, M.G., Gullo, V.P., Ganguly, A.K., Sarre, O., Puar, M.S., and McPhail, A.T. (1990) Macrolactams: A New Class of Antifungal Agents, J. Am. Chem. Soc. 112, 6403–6405.
Hegde, V.R., Patel, M.G., Gullo, V.P., and Puar, M.S. (1991) SCH-38518 and SCH-39185—2 Novel Macrolactam Antifungals, J. Chem. Soc. Chem. Commun., 810–812.
Naruse, N., Tenmyo, O., Kawano, K., Tomita, K., Ohgusa, N., Miyaki, T., Konishi, M., and Oki, T. (1991) Fluvirucin-A1, Fluvirucin-A2, Fluvirucin-B1, Fluvirucin-B2, Fluvirucin-B3, Fluvirucin-B4, and Fluvirucin-B5, New Antibiotics Active Against Influenza A Virus. 1. Production, Isolation, Chemical Properties and Biological Activities, J. Antibiot. 44, 733–740.
Naruse, N., Tsuno, T., Sawada, Y., Konishi, M., and Oki, T. (1991) Fluvirucin-A1, Fluvirucin-A2, Fluvirucin-B1, Fluvirucin-B2, Fluvirucin-B3, Fluvirucin-B4, and Fluvirucin-B5, New Antibiotics Active Against Influenza A Virus. 2. Structure Determination, J. Antibiot. 44, 741–755.
Naruse, N., Konishi, M., Oki, T., Inouye, Y., and Kakisawa, H. (1991) Fluvirucin-A1, Fluvirucin-A2, Fluvirucin-B1, Fluvirucin-B2, Fluvirucin-B3, Fluvirucin-B4, and Fluvirucin-B5, New Antibiotics Active Against Influenza A Virus. 3. The Stereochemistry and Absolute Configuration of Fluvirucin-A1, J. Antibiot. 44, 756–761.
Tomita, K., Oda, N., Hoshino, Y., Ohkusa, N., and Chikazawa, H. (1991) Fluvirucin-A1, Fluvirucin-A2, Fluvirucin-B1, Fluvirucin-B2, Fluvirucin-B3, Fluvirucin-B4 and Fluvirucin-B5, New Antibiotics Active Against Influenza-A Virus. 4. Taxonomy on the Producing Organisms, J. Antibiot. 44, 940–948.
Ui, H., Imoto, M., and Umezawa, K. (1995) Inhibition of Phosphatidylinositol Specific Phospholipase C Activity by Fluvirucin B2 J. Antibiot. 48, 387–390.
Lacey, E., Gill, J.H., Power, M.L., Rickards, R.W., O'Shea, M.G., and Rothshild, J.M. (1995) Bafilolides, Potent Inhibitors of the Motility and Development of the Free-Living Stages of Parasitic Nematodes, Int. J. Parasitol. 25, 349–357.
Umehara, K., Nemoto, K., Ohkubo, T., Miyase, T., Degawa, M., and Noguchi, H. (2004) Isolation of a New 15-Membered Macrocyclic Glycolipid Lactone, Cuscutic Resinoside A from the Seeds of Cuscuta chinensis: A Stimulator of Breast Cancer Cell Proliferation, Planta Med. 70, 299–304.
Yates, D.M., Portillo, V., and Wolstenholme, A.J. (2003) The Avermectin Receptors of Haemonchus contortus and Caenorhabditis elegans, Int. J. Parasitol. 33, 1183–1193.
Wilson, M.L. (1993) Avermectins in Arthropod Vector Management—Prospects and Pitfalls, Parasitol. Today 9, 83–87.
Yen, T.H., and Lin, J.L. (2004) Acute Poisoning with Emamectin Benzoate, J. Toxicol. Clin. Toxicol. 42, 657–661.
Drinyaev, V.A., Mosin, V.A., Kruglyak, E.B., Novik, T.S., Sterlina, T.S., Ermakova, N.V., Kublik, L.N., Levitman, M.K., Shaposhnikova, V.V., and Korystov, Y.N. (2004) Antitumor Effect of Avermectins, Eur. J. Pharmacol. 501, 19–23.
Elegami, A.A., Bates, C., Gray, A.I., Mackay, S.P., Skellern, G.G., and Waigh, R.D. (2003) Two Very Unusual Macrocyclic Flavonoids from the Water Lily Nymphaea lotus, Phytochemistry 63, 727–731.
ElGhazali, G.E.B., ElTohami, M.S., and Elegami, A.A. (1994) Medicinal Plants of the White Nile Provinces, pp. 76–90, Khartoum University Press, Khartoum, Sudan.
Elegami, A.A., Almagboul, A.Z., Omer, M.E.A., and ElTohami, M.S. (2001) Sudanese Plants Used in Folkloric Medicine: Screening for Antibacterial Activity. Part X, Fitoterapia 72, 810–817.
Cosar, C. (1956) Study of Acute Toxicity of Spiramycin in Mice and Its Activity in Experimental Infections of the Same, Therapie (in French) 11, 324–328.
Chain, E.B. (1958), Chemistry and Biochemistry of Antibiotics, Annu. Rev. Biochem. 27, 167–222.
Sugimoto, C., Mitani, K., Nakazawa, M., Sekizaki, T., Terakado, N., and Isayama, Y. (1983) In vitro Susceptibility of Haemophilus somnus to 33 Antimicrobial Agents, Antimicrob. Agents Chemother. 23, 163–165.
Lounes, A., Lebrihi, A., Benslimane, C., Lefrebrve, G., and Germain, P. (1995) Effect of Nitrogen/Carbon Ratio on the Specific Production Rate of Spiramicin by Streptomyces ambofaciens, Process Biochem. 31, 13–20.
Oka, H., Harada, K., Suzuki, M., and Ito, Y. (2000) Separation of Spiramycin Components Using High-Speed Counter-Current Chromatography, J. Chromatogr. 903, 93–98.
Stark, W.M., Daily, W.A., and McGuire, J.M. (1961) A Fermentation Study of the Biosynthesis of Tylosin in Synthetic Media, Rend. Ist. Super. Sanita 1, 340–354.
Hamil, R.L., Haney, M.E., Stamper, M., and Wiley, P.F. (1961) Tylosin, a New Antibiotic. II. Isolation, Properties, and Preparation of Desmycosin, a Microbiologically Active Degradation Product, Antibiot. Chemother. 11, 328–334.
Baltz, R.H., Seno, E.T., Stonessifer, J., and Wild, G.M. (1983) Biosynthesis of the Macrolide Antibiotic Tylosin. A Preferred Pathway from Tylactone to Tylosin, J. Antibiot. 36, 131–141.
Grafe, U., Bocker, H., Reinhardt, G., Tkocz, H., and Thrum, H. (1973) Biosynthesis of the Macrolide Antibiotic A 6599 by Streptomyces hydroscopicus JA 6599 and Activity of the NADP-Dependent Metabolism, Z. Allg. Mikrobiol. (in German) 13, 115–129.
Hata, T., Yamamoto, H., Matsumae, A., and Ito, S. (1953) Leucomycin, a New Antibiotic, J. Antibiot. 6, 87–89.
Osono, T., Oka, Y., Watanabe, S., Okami, Y., and Ishida, H. (1967), A New Antibiotic, Josamycin I. Isolation and Physico-chemical Characteristics, J. Antibiot. 20, 174–180.
Muroi, M., Izawa, M., and Kishi, T. (1972) Structures of Maridomycin 1,3,4,5 and 6 Macrolide Antibiotics, Experientia 28, 129–131.
Muroi, M., Izawa, M., Ono, H., Higashide, E., and Kishi, T. (1972) Isolation of Maridomycins and Structure of Maridomycin II, Experientia 28, 501–502.
Muroi, M., Izawa, M., Ono, H., Higashide, E., and Kishi, T. (1972) Isolation of Maridomycins and Structure of Maridomycin II, Experientia 28, 878–880.
Ono, H., Hasegawa, T., Higashide, E., and Shibata, M. (1973) Maridomycin, a New Macrolide Antibiotic. I. Taxonomy and Fermentation, J. Antibiot. 26, 191–198.
Muroi, M., Izawa, M., Asai, M., Kishi, T., and Mizuno, K. (1973) Maridomycin, a New Macrolide Antibiotic. II. Isolation and Characterization, J. Antibiot. 26, 199–205.
Muroi, M., Izawa, M., and Kishi, T. (1976) Maridomycin, a New Macrolide Antibiotic. X. The Structure of Maridomycin II, Chem. Pharm. Bull. 24, 450–462.
Muroi, M., Izawa, M., and Kishi, T. (1976) Maridomycin, a New Macrolide Antibiotic. XI. The Structures of Maridomycin Components, Chem. Pharm. Bull. 24, 463–478.
Suzuki, M., Takamori, I., Kinumaki, A., Sugawara, Y., and Okuda, T. (1971) The Structures of Antibiotics YL-704 A and B, Tetrahedron Lett. 12, 435–438.
Suzuki, M., Takamori, I., Kinumaki, A., Suguwara, Y., and Okuda, T. (1971) The Structure of Antibiotics YL-704 C1, C2 and W1, J. Antibiot. 24, 904–906.
Umino, K., Takeda, N., Ito, Y., and Okuda, T. (1974) Studies on Pentenomycins. II. The Structures of Pentenomycin I and II, New Antibiotics, Chem Pharm. Bull. 22, 1233–1238.
Kinumaki, A., Takamori, I., Sugawara, Y., Nagahama, N., Suzuki, M., Egawa, Y., Sakuraza, M., and Okuda, T. (1974) Studies on the Macrolide Antibiotic YL-704 Complex. 2. The Structures of New Macrolide Antibiotics YL-704 A1 and B1, J. Antibiot. 27, 102–107.
Kinumaki, A., Takamori, I., Sugawara, Y., Suzuki, M., and Okuda, T. (1974) Studies on the Macrolide Antibiotic YL-704 Complex. 3. The Structures of New Macrolide Antibiotics YL-704 A1 and B1, J. Antibiot. 27, 107–116.
Kinumaki, A., Takamori, I., Sugawara, Y., Suzuki, M., and Okuda, T. (1974) Studies on the Macrolide Antibiotic YL-704 Complex. 4. The Structures of New Macrolide Antibiotics YL-704 A1 and B1, J. Antibiot. 27, 117–126.
Niida, T., Tsuruoka, T., Ezaki, N., Sugawara, Y., Akita, E., and Inoye, S. (1971) A New Antibiotics, SF-837, J. Antibiot. 24, 319–320.
Inouye, S., Tsuruoka, T., Shomura, T., Ezaki, N., and Niida, T. (1971) Studies on Antibiotic SF-837, a New Antibiotic. II. Chemical Structure of Antibiotic SF-837, J. Antibiot. 24, 460–475.
Omoto, S., Inouye, S., and Niita, T. (1971) Separation of Aminoglycosidic Antibiotics by Gas-Liquid Chromatography, J. Antibiot. 24, 430–434.
Inouye, S., Shomura, T., Tsuruoka, T., Omoto, S., and Niida, T. (1972) Isolation and Structure of Two Metabolites of a Macrolide Antibiotic, SF-837 Substances, Chem. Pharm. Bull. 20, 2366–2371.
Tsuruoka, T., Inouye, S., Shomura, T., Ezaki, N., and Niida, T. (1971) Studies on Antibiotic SF-837, a New Antibiotic. IV. Structures of Antibiotics SF-837 A2, A3 and A4, J. Antibiot. 24, 526–536.
Huber, G., Wallhaeusser, K.H., Fries, L., Steigler, A., and Weidenmueller, H.L. (1962) Niddamycin, a New Macrolide Antibiotic, Arzneimittelforschung (in German) 12, 1191–1195.
Masamune, S., Bates, G.S., and Corcoran, J.W. (1977) Macrolides. Recent Progress in Chemistry and Biochemistry, Angew. Chem. Int. Ed. Eng. 16, 585–607.
Sawada, Y., Tsuno, T., Miyaki, T., Naito, T., and Oki, T. (1989) New Cirramycin Family Antibiotics F-1 and F-2. Selection of Producer Mutants, Fermentation, Isolation, Structural Elucidation and Antibacterial Activity, J. Antibiot. 42, 242–253.
Tanba, H., Kawasaki, T., Mitadera, Y., Soga, H., Shinkai, H. Otsuki, N., Sakakibara, M., and Tatsuta, K. (1988) M119-A, A Novel Macrolide Antibiotic, Jpn. J. Antibiot. (in Japanese) 41, 604–605.
Brufani, M., and Keller-Schierlein, W. (1966) Metabolic Products of Microorganisms, 54. On the Sugar Building Stones of Angolamycin: l-Mycarose, d-Mycinose and d-Angolosamine, Helv. Chim. Acta. (in German) 49, 1962–1970.
Shimi, I.R., Shoukry, S., and Ali, F.T. (1979) Staphcocomycin, a New Basic Macrolide Antibiotic, J. Antibiot. 32, 1248–1255.
Koshiyama, H., Okanishi, M., Ohmori, T., Miyaki, T., Tsukiura, H., Matsuzaki, M., and Kawaguchi, H. (1963) Cirramycin, a New Antibiotic, J. Antibiot. 16, 59–66.
Koshiyama, H., Tsukiura, H., Fujisawa, K., Konishi, M., and Hatori, M. (1969), Studies on Cirramycin A1. I. Isolation and Characterization of Cirramycin A1, J. Antibiot. 22, 61–64.
Tsukiura, H., Konishi, M., Saka, M., Naito, T., and Kawaguchi, H. (1969), Studies on Cirramycin A1. 3. Structure of Cirramycin A1, J. Antibiot. 22, 89–99.
Wagman, G.H., Waitz, J.A., Marquez, J., Murawaski, A., Oden, E.M., Testa, R.T., and Weinstein, M.J. (1972) A New Micromonospora Produced Macrolide Antibiotic, Rosamicin, J. Antibiot. 25, 641–646.
Puar, M.S., and Schumacher, D. (1990) Novel Macrolides from Micromonospora rosaria, J. Antibiot. 43, 1497–1501.
Furumai, T., Maezawa, I., Matsuzawa, N., Yano, S., Yamaguchi, T., Takeda, K., and Okuda, T. (1977) Macrolide Antibiotics M-4365 Produced by Micromonospora. I. Taxonomy, Production, Isolation, Characterization and Properties, J. Antibiot. 30, 443–449.
Kinumaki, A., Harada, K., Suzuki, T., Suzuki, M., and Okuda, T. (1977) Macrolide Antibiotics M-4365 Produced by Micromonospora. II. Chemical Structures, J. Antibiot. 30, 450–454.
Morin, R.B., Gorman, M., Hamil, R.L., and Demarco, P.V. (1970) The Structure of Tylosin, Tetrahedron Lett. 11, 4737–4740.
Baltz, R.H., and Seno, E.T. (1981) Properties of Streptomyces fradiae Mutants Blocked in Biosynthesis of the Macrolide Antibiotic Tylosin, Antimicrob. Agents Chemother. 20, 214–225.
Kirst, H.A., Wild, G.M., Baltz, R.H., Seno, E.T., Hamill, R.L., Paschal, J.W., and Dorman, D.E. (1983) Elucidation of Structure of Novel Macrolide Antibiotics Produced by Mutant Strains of Streptomyces fradiae, J. Antibiot. 36, 376–382.
Kirst, H.A., Wild, G.M., Baltz, R.H., Hamill, R.L., Ott, J.L., Counter, F.T., and Ose, E.E. (1982) Structure-Activity Studies Among 16-Membered Macrolide Antibiotics Related to Tylosin, J. Antibiot. 35, 1675–1682.
Hayashi, M., Kinoshita, K., Sudate, Y., Satoi, S., Sakakibara, H., Harada, K., and Suzuki, M. (1983) Mycinamicins, New Macrolide Antibiotics. VII. Structures of Minor Components, Mycinamicin VI and VII, J. Antibiot. 36, 175–178.
Satoi, S., Muto, N., Hayashi, M., Fujii, T., and Otani, M. (1980) Mycinamicins, New Macrolide Antibiotics. I. Taxonomy, Production, Isolation, Characterization and Properties, J. Antibiot. 33, 364–376.
Hayashi, M., Ohno, M., Katsumata, S., Satoi, S., Harada, K.I., Takeda, M., and Suzuki, M. (1981) Mycinamicins, New Macrolide Antibiotics. IV. Structure of Mycinamicin III, J. Antibiot. 34, 276–281.
Kinoshita, K., Satoi, S., Hayashi, M., Harada, K., Suzuki, M., and Nakatsu, K. (1985) Mycinamicins, New Macrolide Antibiotics. VIII. Chemical Degradation and Absolute Configuration of Mycinamicins, J. Antibiot. (Tokyo) 38, 522–526.
Woo, P.W.K., Dion, H.W., and Bartz, Q.R. (1961) Chemistry of Chalcose, a 3-Methoxy-4,6-dideoxyhexose, J. Am. Chem. Soc. 83, 3352–3353.
Woo, P.W.K., Dion, H.W., and Bartz, Q.R. (1962) A Degradation Product of Chalcomycin: 2,4-Dimethyl-3-chalsocyloxy-6-oxoheptanoic Acid, J. Am. Chem. Soc. 84, 1512–1513.
Woo, P.W.K., Dion, H.W., and Johnson, L.F. (1962) The Stereochemistry of Chalcose, A Degradation Product of Chalcomycin, J. Am. Chem. Soc. 84, 1066–1067.
Lefemine, D.V., Barbatschi, F., Dann, M., Thomas, S.O., Kunstmann, M.P., Mitscher, L.A., and Bohonos, N. (1963) Neutramycin, a New Neutral Macrolide Antibiotic, Antimicrob. Agents Chemother 9, 41–44.
Kunstmann, M.P., and Mitscher, L.A. (1965) Some Additional Observations on the Chemical Nature of Neutramycin, Experientia 21, 372–373.
Mitscher, L.A., and Kunstmann, M.P. (1969) The Structure of Neutramycin, Experientia 25, 12–13.
Hauske, J.R., Dibrino, J., Guadliana, M., and Kostek, G. (1986) Structure Elucidation of a New Neutral Macrolide Antibiotic, J. Org. Chem. 51, 2808–2814.
Kunstmann, M.P., Mitscher, L.A., and Patterson, E.L. (1964) Aldgamycin E, a New Neutral Macrolide Antibiotic, Antimicrob. Agents Chemother. 10, 87–90.
Mizobuchi, S., Mochizuki, J., Soga, H., Tanba, H., and Inoue, H. (1986) Aldgamycin G, a New Macrolide Antibiotic, J. Antibiot. 39, 1776–1778.
Chatterjee, S., Reddy, G.C.S., Franco, C.M.M., Rupp, R.H., Ganguli, B.N., Fehlhaber, H.W., and Kogler, H. (1987) Swalpamycin, a New Macrolide Antibiotic. II. Structure Elucidation, J. Antibiot. 40, 1368–1374.
Franco, C.M.M., Gandli, J.N., Chatterjee, S., and Ganguli, B.N. (1987) Swalpamycin, a New Macrolide Antibiotic. I. Taxonomy of the Producing Organism, Fermentation, Isolation and Biological Activity, J. Antibiot. 40, 1361–1367.
Park, H.-R., Furihata, K., Hayakawa, Y., and Shin-ya, K. (2002) Versipelostatin, a Novel GRP78/Bip Molecular Chaperone Down-regulator of Microbial Origin, Tetrahedron Lett. 43, 6941–6945.
Roy, B., and Lee, A.S. (1999) The Mammalian Endoplasmic Reticulum Stress Response Element Consists of an Evolutionarily Conserved Tripartite Structure and Interacts with a Novel Stress-Inducible Complex, Nucleic Acids Res. 27, 1437–1443.
Sausville, E.A. (2004) Versipelostatin: Unfolding an Unsweetened Death, J. Natl. Cancer Instit. 96, 1266–1267.
Chijiwa, S., Park, H.-R., Furihata, K., Ogata, M., Endo, T., Kuzuyama, T., Hayakawa, Y., and Shin-ya, K. (2003) Biosynthetic Studies of Versipelostatin, a Novel 17-Membered α-Tetronic Acid Involved Macrocyclic Compound Isolated from Streptomyces versipellis, Tetrahedron Lett. 44, 5897–5900.
Kitagawa, I., Ohashi, K., Baek, N.I., Sakagami, M., Yoshikawa, M., and Shibuya, H. (1997) Indonesian Medicinal Plants. XIX. 1) Chemical Structures of Four Additional Resin Glycosides, Mammosides A, B, H1 and H2, from the Tuber of Merremia mammosa (Convolvulaceae), Chem. Pharm. Bull. 45, 786–794.
Omura, S., Tanaka, Y., Nakagawa, A., Iwai, Y., Inoue, M., and Tanaka, H. (1982) Irumamycin, a New Antibiotic Active Against Phytopathogenic Fungi, J. Antibiot. 35, 256–257.
Fourati-Ben Fguira, L., Fotso, S., Ben Ameur-Mehdi, R., Mellouli, L., and Laatsch, H. (2005) Purification and Structure Elucidation of Antifungal and Antibacterial Activities of Newly Isolated Streptomyces sp. strain US80, Res. Microbiol., in press.
Kinashi, H., Someno, K., and Sakaguchi, K. (1984) Isolation and Characterization of Concanamycins A, B and C, J. Antibiot. 37, 1333–1343.
Malikova, M., Shi, J., and Kandror, K.V. (2004) V-type ATPase Is Involved in Biogenesis of GLUT4 Vesicles, Am. J. Physiol. Endocrinol. Metab. 287, E547-E552.
Hochlowski, J.E., Swanson, S.J., Ranfranz, L.M., Whittern, D.N., Buko, A.M., and McAlpine, J.B. (1987) Tiacumicins, a Novel Complex of 18-Membered Macrolide Antibiotics. II. Isolation and Structure Determination, J. Antibiot. 40, 575–588.
Theriault, R.J., Karwowski, J.P., Jackson, M., Girolami, R.L., Sunga, G.N., Vojtko, C.M., and Coen, L.J. (1987) Tiacumicins, a Novel Complex of 18-Membered Macrolide Antibiotics. I. Taxonomy, Fermentation and Antibacterial Activity, J. Antibiot. 40, 567–574.
Coronelli, C., White, R.J., Lancini, G.C., and Parenti, F. (1975) Lipiarmycin, A New Antibiotic from Actinoplanes. II. Isolation, Chemical Biological and Biochemical Characterization, J. Antibiot. 28, 253–259.
Parenti, F., Pagan, H., and Beretta, G. (1975) Lipiarmycin, a New Antibiotic from Actinoplanes. I. Description of the Producer Strain and Fermentation Studies, J. Antibiot. 28, 247–252.
Omura, S., Imamura, N., Oiwa, R., Kuga, H., Iwata, R., Masuma, R., and Iwai, Y. (1986) Clostomicins, New Antibiotics Produced by Micromospora echinospora subsp. armeniaca subsp. nov. I. Production, Isolation and Physicochemical and Biological Properties, J. Antibiot. 39, 1407–1412.
Sergio, S., Pirali, G., White, R., and Parenti, F. (1975) Lipiarmycin, a New Antibiotic from Actinoplanes. III. Mechanism of Action, J. Antibiot. 28, 543–549.
Bloor, S.J. (1998) A Macrocyclic Anthocyanin from Red/Mauve Carnation Flowers, Phytochemistry 49, 225–228.
Nakayama, M., Koshioka, M., Yoshida, H., Kan, Y., Fukui, Y., Koike, A., and Yamaguchi, M.-A. (2000) Cyclic Malyl Anthocyanins in Dianthus caryophyllus, Phytochemistry 55, 937–939.
Gonnet, J.-F., and Fenet, B. (2000) “Cyclamen Red” Colors Based on a Macrocyclic Anthocyanin in Carnation Flowers, J. Agric. Food Chem. 48, 22–26.
Fukui, Y., Tanaka, Y., Kusumi, T., Iwashita, T., and Nomoto, K. (2003) A Rationale for the Shift in Colour Towards Blue in Transgenic Carnation Flowers Expressing the Flavonoid 3′,5′-Hydroxylase Gene, Phytochemistry 63, 15–23.
Shindo, K., Kamishohara, M., Odagawa, A., Matsuoka, M., and Kawai, H. (1993) Vicenistatin, a Novel 20-Membered Macrocyclic Lactam Antitumor Antibiotic, J. Antibiot. 46, 1076–1081.
Ryu, G., Choi, W.C., Hwang, S., Yeo, W.H., Lee, C.S., and Kim, S.K. (1999) Tetrin C, a New Glycosylated Polyene Macrolide Antibiotic Produced by Streptomyces sp. GK9244, J. Nat. Prod. 62, 917–919.
Pathirana, C., Tapiolas, D., Jensen, P.R., Dwight, R., and Fenical, W. (1991) Structure Determination of Maduralide: A New 24-Membered Ring Macrolide Glycoside Produced by a Marine Bacterium (Actinomycetales), Tetrahedron Lett. 32, 2323–2326.
Struyk, A.P., Hoette, I., Drost, G., Waisvisz, J.M., Van Eek, T., and Hoogerheide, J.C. (1957) Pimaricin, a New Antifungal Antibiotic, Antibiot. Annu. 5, 878–885.
Gil, J.A., and Martin, J.F. (1997) Polyene Antibiotics, in Biotechnology of Antibiotics, 2nd edn. (Strohl, W.R., ed.), pp. 551–576, Marcel Dekker, New York.
Mendes, M.V., Recio, E., Fouces, R., Luiten, R., Martín, J.F., and Aparicio, J.F. (2001) Engineered Biosynthesis of Novel Polyenes: A Pimaricin Derivative Produced by Targeted Gene Disruption in Streptomyces natalensis, Chem. Biol. 8, 635–644.
Okami, Y., Utahara, R., Nakamura, S., and Umezawa, H. (1954) Studies on Antibiotic Actinomycetes. IX. On Streptomyces Producing a New Antifungal Substance Mediocidin and Antifungal Substances of Fungicidin-Rimocidin-Chromin Group, Eurocidin Group and Trichomycin-Ascosin-Candicidin Group, J. Antibiot. 7, 98–103.
Osato, T., Ueda, M., Fukuyama, S., Yagishita, K., Okami, Y., and Umezawa, H. (1955) Production of Tertiomycin (a new antibiotic substance), Azomycin and Eurocidin by S. eurocidicus, J. Antibiot. 8, 105–109.
Nakagomi, K., Takeuchi, M., Tanaka, H., Tomizuka, N., and Nakajima, T. (1990) Studies on Inhibitors of Rat Mast Cell Degranulation Produced by Microorganisms. I. Screening of Microorganisms, and Isolation and Physico-chemical Properties of Eurocidins C, D and E, J. Antibiot. (Tokyo) 43, 462–469.
Tanaka, Y., Komaki, H., Yazawa, K., Mikami, Y., Nemoto, A., Tojyo, T., Komaki, K., Shigemori, H., and Kobayashi, J. (1997) Brasilinolide A, a New Macrolide Antibiotic Produced by Nocardia brasiliensis: Producing Strain, Isolation and Biological Activity, J. Antibiot. 50, 1036–1041.
Mikami, Y., Komaki, H., Imai, T., Yazawa, K., Nemoto, A., Tanaka, Y., and Graefe, U. (2000) A New Antifungal Macrolide Component, Brasilinolide B, Produced by Nocardia brasiliensis, J. Antibiot. 53, 70–74.
Komatsu, K., Tsuda, M., Tanaka, Y., Mikami, Y., and Kobayashi, J. (2004) Absolute Stereochemistry of Immuno-suppressive Macrolide Brasilinolide A and Its New Congener Brasilinolide C, J. Org. Chem. 69, 1535–1541.
Kong, F., Liu, D.Q., Nietsche, J., Tischler, M., and Carter, G.T. (1999) Colubricidin A, a Novel Macrolide Antibiotic from a Streptomyces sp., Tetrahedron Lett. 40, 9219–9223.
Brautaset, T., Sekurova, O.N., Sletta, H., Ellingsen, T.E., Strøm, A.R., Valla, S., and Zotchev, S.B. (2000) Biosynthesis of the Polyene Antifungal Antibiotic Nystatin in Streptomyces noursei ATCC 11455: Analysis of the Gene Cluster and Deduction of the Biosynthetic Pathway, Chem. Biol. 7, 395–403.
Oura, M., Sternberg, T.H., and Wright, E.T. (1955–1956) A New Antifungal Antibiotic, Amphotericin B, Antibiot. Annu. 3, 566–573.
Gallis, H.A., Drew, R.H., and Pickard, W.W. (1990) Amphotericin B: 30 Years of Clinical Experience, Rev. Infect. Dis. 12, 308–329.
Lechevalier, H. (1953) Fungicidal Antibiotics, Produced by Actinomycetes, Candicidin, Presse Med. 61, 1327–1328.
Roberts, C.L., and Sullivan, J.J. (1965) Moniliasis. The Use of Candicidin Vaginal Ointment for Treatment, Calif. Med. 103, 109–111.
Friedel, H.J. (1966) Candicidin, a New Vaginal Monilicide. A Test Series, MD State Med. J. 15, 36–37.
Kivinen, S., Tarkkila, T., Laakso, L., Laakso, K. (1979) Short-Term Topical Treatment of Vulvovaginal Candidiasis with the Combination of 5-Fluorocytosine and Candicidin, Curr. Med. Res. Opin. 6, 88–92.
Jensen, K.M., and Madsen, P.O. (1983) Candicidin Treatment of Prostatism: A Prospective Double-Blind Placebo-Controlled Study, Urol. Res. 11, 7–10.
Grabley, S., Kretzschmar, G., Mayer, M., Phillips, S., Thiericke, R., Wink, R., and Zeeck, A. (1993) Secondary Metabolites by Chemical-Screening. 2. Oasomycins, New Macrolactones of the Desertomycin Family, Liebigs Ann. Chem. 5, 573–579.
Dolak, L.A., Reusser, F., Baczynskyj, L., Mizsak, S.A., Hannon, B.R., and Castle, T.M. (1983) Desertomycin: Purification and Physical-Chemical Properties, J. Antibiot. 36, 13–19.
Uri, J.V. (1986) Desertomycin—A Potentially Interesting Antibiotic (a review), Acta Microbiol. Hung 33, 271–283.
Mukhopadhyay, T., Nadkarni, S.R., Bhat, R.G., Gupte, S.V., Ganguli, B.N., Petry, S., and Kogler, H. (1999) Mathemycin B, a New Antifungal Macrolactone from Actinomycete Species HIL Y-8620959, J. Nat. Prod. 62, 889–890.
Mukhopadhyay, T., Vijayakumer, E.K.S., Nadkarni, S.R., Fehlhader, H.W., Kogler, H., and Petry, S. (1998) Mathemycin A, a New Antifungal Macrolactone from Actinomycete sp. HIL Y-8620959—II. Structure Elucidation, J. Antibiot. 51, 582–585.
Nadkarni, S.R., Mukhopadhyay, T., Bhat, R.G., Gupte, S.V., Ganguli, B.N., and Sachse, B. (1998) Mathemycin A, a New Antifungal Macrolactone from Actinomycete sp. HIL Y-8620959—I. Fermentation, Isolation, Physico-chemical Properties and Biological Activities, J. Antibiot. 51, 579–581.
York, W.S. (1995) A Conformational Model for Cyclic β-(1→2)-Linked Glucans Based on NMR Analysis of the β-Glucans Produced by Xanthomonas campestris, Carbohydr. Res. 278, 205–225.
Kates, M., Kushner, D.J., and Matheson, A.T. (eds.) (1993) The Biochemistry of Archaea, Elsevier, New York.
Uda, I., Sugai, A., Itoh, Y.H., and Itoh, T. (2001) Variation in Molecular Species of Polar Lipids from Thermoplasma acidophilum Depends on Growth Temperature, Lipids 36, 103–105.
Uda, I., Sugai, A., Kon, K., Ando, S., Itoh, Y.H., and Itoh, T. (1999) Isolation and Characterization of Novel Neutral Glycolipids from Thermoplasma acidophilum, Biochim. Biophys. Acta 1439, 363–370.
Matsumura, S., Imai, K., Yoshikawa, S., Kawada, K., and Uchirobi, T. (1990) Bola-form Amphiphilic Compounds: Their Surface Activities, Biodegradability, and Antimicrobial Properties, J. Am. Oil Chem. Soc. 67, 996–1001.
Müllerfahrnow, A., Saenger, W., Fritsch, D., Schneider, P., and Fuhrhop, J.-H. (1993) Molecular and Crystal Structure of the Bola-Amphiphile n-[8-(d-gluconamido)octyl]-d-gluconamide, Carbohydr. Res. 242, 11–20.
Munoz, S., Mallen, J., Nakano, A., Chen, Z., Gay, I., Echegoyen, L., and Gokel, G.W. (1993) Ultrathin Monolayer Lipid Membranes from a New Family of Crown Ether-Based Bola-Amphiphiles, J. Am. Chem. Soc. 115, 1705–1711.
Newkome, G.R., Moorefield, C.N., Baker, G.R., Behera, R.K., Escamilla, G.H., and Saunders, M.J. (1992) Chemistry of Micelles. 16. Supramolecular Self-Assemblies of 2-Directional Cascade Molecules—Automorphogenesis, Angew. Chem. Int. Ed. Engl. 31, 917–919.
Fuhrhop, J.-H., Spiroski, D., and Boettcher, C. (1993) Molecular Monolayer Rods and Tubules Made of α-(l-lysine),ω-(amino) Bolaamphiphiles, J. Am. Chem. Soc. 115, 1600–1601.
Jayasuriya, N., Bosak, S., and Regen, S.L. (1990) Design, Synthesis, and Activity of Membrane-Disrupting Bolaphiles, J. Am. Chem. Soc. 112, 5844–5850.
Jayasuriya, N., Bosak, S., and Regen, S.L. (1990) Supramolecular Surfactants: Polymerized Bolaphiles Exhibiting Extraordinarily High Membrane-Disrupting Activity, J. Am. Chem. Soc. 112, 5851–5854.
Moss, R.A., and Li, J.-M. (1992) Bilayer-Bridging Bolaamphiphilic Lipids, J. Am. Chem. Soc. 114, 9227–9229.
Yamauchi, K., and Kinoshita, M. (1993) Highly Stable Lipid-Membranes from Archaebacterial Extremophiles, Prog. Polym. Sci. 18, 763–804.
Bertho, J.-N., Coué, A., Ewing, D.F., Goodby, J.W., Letellier, P., Mackenzie, G., and Plusquellec, D. (1997) Novel Sugar Bola-Amphiphiles with a Pseudo Macrocyclic Structure, Carbohydrate Res. 300, 341–346.
Satgé, C., Granet, R., Verneuil, B., Champavier, Y., and Krausz, P. (2004) Synthesis and Properties of New Bolaform and Macrocyclic Galactose-Based Surfactants Obtained by Olefin Metathesis, Carbohydrate Res. 339, 1243–1254.
Nyman, E.S., and Hynninen, P.H. (2004) Research Advanced in the Use of Tetrapyrrolic Photosensitizers for Photodynamic Therapy, J. Photochem. Photobiol. B: Biol. 73, 1–28.
Sessler, J.L., and Miller, R.A. (2000) Texaphyrins: New Drugs with Diverse Clinical Applications in Radiation and Photodynamic Therapy, Biochem. Pharmacol. 59, 733–739.
Sharman, W.M., Allen, C.M., Van Lier, A.E., and Van Lier, J.E. (1999) Photodynamic Therapeutics: Basic Principles and Clinical Applications, Drug Discov. Today 4, 507–517.
Dolphin, D. (1994) Photomedicine and Photodynamic Therapy, Can. J. Chem. 72, 1005–1013.
Synytsya, A., Král, V., Blechová, M., and Volka K. (2004) Biolocalisation and Photochemical Properties of Two Novel Macrocyclic Photosensitisers: A Spectroscopic Study, J. Photochem. Photobiol. B: Biol. 74, 73–84.
Fujimoto, K., Miyata, T., and Aoyama, Y. (2000) Saccharide-Directed Cell Recognition and Molecular Delivery Using Macrocyclic Saccharide Clusters: Masking of Hydrophobicity to Enhanced the Saccharide Specificity, J. Am. Chem. Soc. 122, 3558–3559.
Menger, F.M., Bian, J., Sizova, E., Martinson, D.E., and Seredyuk, V.A. (2004) Bolaforms with Fourteen Galactose Units: A Proposed Site-Directed Cohesion of Cancer Cells, Org. Lett. 6, 261–264.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Dembitsky, V.M. Astonishing diversity of natural surfactants: 2. Polyether glycosidic ionophores and macrocyclic glycosides. Lipids 40, 219–248 (2005). https://doi.org/10.1007/s11745-005-1378-0
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-005-1378-0